Hua Han Health (00587), a Hong Kong listed company, issued an announcement. On August 4th, HKAB issued its liquidation regulation
Hua Han Health (00587), a Hong Kong listed company, issued an announcement. On August 4th, HKAB issued its liquidation regulations, and its indirectly controlled hospital, Liupanshui Du Liang People's Hospital, declared bankruptcy and reorganization.
Author | Nanxing
Source | See the medical profession (ID: Vistamed)
Click on the avatar above to pay attention to "seeing the medical profession", and there are materials every day!
Recently, Hua Han Health (00587), a Hong Kong listed company, issued an announcement. On August 4th, the Hong Kong court issued relevant regulations on liquidation, and its indirectly controlled hospital, Liupanshui Du Liang People's Hospital, declared bankruptcy and reorganization.
After three years of suspension, the company hospital went bankrupt and reorganized.
According to "See the Medical World", Huahan Health realized the IPO of Hong Kong stocks as early as 2002. According to the data, Huahan Health has two major businesses: Chinese medicine products with women as the main users, and anti-tumor drugs and western medicine products. In addition, in recent years, Huahan Health has invested in many hospitals, among which Liupanshui Du Liang People's Hospital is one.
According to public information, Du Liang People's Hospital of Liupanshui City (hereinafter referred to as "Du Liang People's Hospital") was established in September 20 14, and it is the flagship project of Huahan Health in the medical industry. According to the survey, Hua Han Health indirectly holds 68% of the shares of Liupanshui Du Liang Hospital Company, of which Guizhou Hanfang Health Industry Investment Co., Ltd. holds 68% and Liupanshui People's Hospital (public hospital) holds 32%.
2065438+In February, 2005, the project of "Du Liang People's Hospital" officially started construction. According to the data at that time, the hospital covers an area of 1.80 mu, with a total construction area of 250,700 square meters. It is estimated that the total investment will be nearly 2 billion yuan, and the designed beds will be 1.02 million. It is planned to build a three-level first-class general hospital and a regional medical center in western Guizhou.
But by 20 16, Hua Han's health began to be in crisis. According to Hongkan Finance, in August of that year, Emerson, a well-known short-selling institution, publicly bearish on Huahan Health, saying that Huahan Health's gross profit margin was too high, and its sales revenue and net profit were seriously exaggerated. Affected by this, Huahan Health's share price fell by more than one-third in the short term.
2065438+In September 2006, Huahan Health announced the suspension of trading and has not resumed trading so far.
A number of Huahan Health shareholders said that before and after the suspension of trading, high-quality assets such as Guizhou Xinhanfang Bio, a subsidiary of Huahan Health, were stripped without announcement, and most of the recipients had no pharmaceutical industry background and human resources. Some investors accused the actual controller of being suspected of hollowing out listed companies.
At the end of last year, Liupanshui Branch of Guizhou Bank applied for bankruptcy reorganization of Du Liang People's Hospital on the grounds that the operating conditions of Liupanshui Du Liang People's Hospital Co., Ltd. deteriorated, and it was unable to pay off the applicant's debts due, and many debts could not be repaid when due, which obviously lost its solvency.
The civil judgment of Liupanshui Intermediate People's Court No.2019 65438+February 1 1 confirmed that the total debt of Du Liang People's Hospital in Liupanshui City was 380 million yuan; From 20 19 to 10, Du Liang People's Hospital was sued by China Construction Sixth Engineering Bureau Co., Ltd., and the object of the lawsuit was 372 million yuan.
It is reported that by the end of 20 19, the main project of Du Liang People's Hospital has been completed. However, due to the broken capital chain of Guizhou Hanfang Health Industry Investment Co., Ltd., the major shareholder of the hospital, it is impossible to continue investing and the project cannot be completely closed. Only one medical examination center operates, with a monthly operating income of about 500,000 yuan, and more than 200 employees are paid monthly 100 yuan, and the income is far from paying employees' wages, bank interest,
In March this year, the Intermediate People's Court of Liupanshui City, Guizhou Province made a ruling on the case that Liupanshui Branch of Guizhou Bank applied for bankruptcy and reorganization of Du Liang Hospital in Liupanshui City, and on April 30, it ruled that Du Liang People's Hospital in Liupanshui City was merged into Liupanshui for bankruptcy and reorganization.
Listed companies need to be cautious in transforming medical care.
In recent years, the investment of listed companies in hospitals is very hot, but there are not a few bleak medical projects.
Due to the termination of the listing of A-shares and B-shares of the listed company Great Wall of China, Wuhan Commercial Hospital was auctioned at a price of 50% not long ago and was finally auctioned. This hospital once held the aura of "the first state-owned hospital with successful restructuring" and declared bankruptcy after only three years of marriage with listed companies.
Coincidentally, Hengkang Medical, the first private hospital, was recently sued by two trust companies. In 20 17, Hengkang Medical successively ate many hospitals such as Henan Lankao First Hospital, Lankao Shuyang Hospital and Lankao Oriental Hospital. But after only one year, these hospitals were sold in succession. At the same time, Hengkang Medical suffered serious losses for two consecutive years and faced the risk of delisting.
2065438+On May 9, 2009, Kangmei Pharmaceutical was reported to have cashed in 30 billion yuan, and its market value evaporated by more than 20 billion yuan in five trading days. For the hospitals under its investment management, the previously planned investment funds are at risk of shrinking sharply, and the sale of hospital assets may be a high probability event.
For some listed companies' roller coaster medical investment, the insiders reminded that medical investment is not a good business to make quick money, but a medium-and long-term strategic investment, otherwise it will not only be difficult to make a profit, but also be mired in a quagmire. (This article is published for "Seeing the Medical World". Reprinting must be authorized, and the author and source should be indicated at the beginning of the article. )